PEG-IFNα

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus InfectionNCT04856085VIRPhase 2Completed2026-03-16Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.